AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Aviglip MF Tablet

Prescription Icon
Prescription Required

Marketer

Avinash Health Products Pvt Ltd

Salt Composition

Glipizide (NA) + Metformin (NA)

Overview Aviglip MF Tablet

Diabex Duo tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medicine even if you feel well; discontinuation without consulting your doctor can lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Diabex Duo is just one element of a comprehensive diabetes management plan, which should also incorporate a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are crucial in controlling diabetes. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to identify hypoglycemia symptoms—such as sweating, dizziness, headache, and tremors—and how to manage them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment; it may not be appropriate in all cases. Pregnant or breastfeeding women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to monitor blood cell counts and liver function.

Uses of Aviglip MF Tablet

Managing type 2 diabetes

Major Benefits of Aviglip MF Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Aviglip MF Tablet with a meal.

Common Side effects of Aviglip MF Tablet:

  • Hypoglycemia (low blood glucose level)
  • Diarrhea
  • Headache
  • Upper respiratory tract infection

How to use Aviglip MF Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Aviglip MF Tablets should be administered with food.

How Aviglip MF Tablet works:

Aviglip MF tablets contain a dual-action formulation of glipizide and metformin, both effective in managing blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Aviglip MF Tablet.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Aviglip MF Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Aviglip MF Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Aviglip MF Tablets cautiously, potentially requiring dose modification under medical supervision. The medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Aviglip MF Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically recommended for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Aviglip MF Tablet :

Should you forget a dose of Aviglip MF Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Aviglip MF Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Aviglip MF Tablet

Aviglip MF tablets contain glipizide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise regimen. Glipizide stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. This dual-agent therapy is unsuitable for treating type 1 diabetes.
Taking Aviglip MF Tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Aviglip MF Tablet use may result in hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Indeed, Aviglip MF Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed MALA (Metformin-associated lactic acidosis), is uncommon but linked to metformin use. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those who consume significant alcohol. Potential symptoms include muscular pain or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Aviglip MF Tablet and seek immediate medical attention.
Prolonged use of Aviglip MF Tablets can indeed lead to Vitamin B12 deficiency. This medication impedes the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Aviglip MF Tablet is contraindicated for individuals exhibiting hypersensitivity to any constituent or inactive ingredient. Its use should also be avoided in patients with moderate to severe renal impairment and those presenting with underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Aviglip MF Tablet and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Store the medication in its original, tightly sealed container, following all storage guidelines printed on the packaging. Discard any remaining medication and ensure it remains inaccessible to children, pets, and others.
Aviglip MF Tablet
30
MRP 37
18% off